Augustine Therapeutics
FranceWho owns Augustine Therapeutics?
Augustine Therapeutics is a French Biotech company, currently owned by Jeito Capital since 2025 and 3 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
- ·Co-held by AdBio Partners, Novo Holdings, Asabys Partners and Jeito Capital since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
More from Jeito II
Other portfolio companies in the same fund.
Denmark
US
NetherlandsMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Augustine Therapeutics?
Augustine Therapeutics is currently owned by Jeito Capital, Novo Holdings and 2 others, through Jeito II, since 2025.
When did Jeito Capital and 3 others acquire Augustine Therapeutics?
Jeito Capital and 3 others acquired Augustine Therapeutics in 2025.
Who has owned Augustine Therapeutics over time?
Augustine Therapeutics has been through 4 private-equity ownership periods: AdBio Partners · via AFB Fund II · since 2019; Novo Holdings · via Novo Holdings Venture Investments · since 2024; Asabys Partners · via Sabadell Asabys Health Innovation Investments II · since 2024; Jeito Capital · via Jeito II · since 2025.